BioNTech
second quarter financial results unaudited balance sheet cash and cash equivalents of as of june full year guidance and for the full year offering and the expected net proceeds from the private investment are expected to the next months | BioNTech
Company
Deck Type
Sector
Industry
Deck date
August 2020
Slide
26 of 28
Related slides by other companies
Cano Health
Results
November 2021
guidance full year | Cano Health
Cano Health
Investor Presentation
November 2021
guidance full year | Cano Health
Avantor
Investor Day
September 2021
full year guidance | Avantor
Coursera
Results
July 2023
guidance adjusted | Coursera
Other recent decks by BioNTech
See all presentations (12 decks)
Investor Presentation
August 2022
Results
August 2022
Investor Day
June 2022
Results
March 2022
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights